StockWatch
·
Specialty Chemicals
Quarterly Updates23 May 2026, 08:30 pm

Anupam Rasayan FY26 Revenue Up 65% YoY to ₹23,836 Mn

AI Summary

Anupam Rasayan India Ltd announced its FY26 financial results, reporting a 65% YoY increase in total revenue to ₹23,836 Mn. EBITDA rose by 32% YoY to ₹5,430 Mn, with a margin of 23%. Profit After Tax increased by 39% YoY to ₹2,222 Mn. Q4FY26 revenue increased by 26% YoY to ₹6,392 Mn, while EBITDA decreased by 6% YoY to ₹1,407 Mn, with a margin of 22%. The company highlighted the acquisition of Jayhawk Fine Chemicals and a definitive agreement to acquire Bliss GVS Pharma.

Key Highlights

  • FY26 Revenue increased by 65% YoY to ₹23,836 Mn.
  • FY26 EBITDA increased by 32% YoY to ₹5,430 Mn, with a 23% margin.
  • FY26 Profit After Tax increased by 39% YoY to ₹2,222 Mn.
  • Q4FY26 Revenue increased by 26% YoY to ₹6,392 Mn.
  • Company acquired Jayhawk Fine Chemicals and agreed to acquire Bliss GVS Pharma.